Class 2 Medicines Recall: Novartis Pharmaceuticals UK, Lucentis 10 mg/ml solution for injection in pre-filled syringe EL (21)A/36
Novartis Pharmaceuticals UK are recalling the above batch due to a faulty plunger stopper which has led to an increased number of customer complaints relating to the plunger being difficult to press down. The faulty plunger stopper batch has only been used in batch 21B15IA and no other batches of Lucentis are impacted.
MDR Number: MDR 017-12/21
Company name: Novartis Pharmaceuticals UK
Product description: Lucentis 10 mg/ml solution for injection in pre-filled syringe, 5ml, (PLGB 00101/1103 EU/1/06/374/003)
Details of the affected batch:
Batch Number |
Expiry Date |
Pack Size |
First Distributed |
21B15IA |
Jan 2024 |
1 |
7th September 2021 |
Active Pharmaceutical Ingredient: Ranibizumab
Brief description of problem:
Novartis Pharmaceuticals UK are recalling the above batch due to a faulty plunger stopper which has led to an increased number of customer complaints relating to the plunger being difficult to press down. The faulty plunger stopper batch has only been used in batch 21B15IA and no other batches of Lucentis are impacted.
Advice to Healthcare Professionals:
Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Company contacts for further information:
For more information or medical information queries, please contact: 01276 698370, or email medinfo.uk@novartis.com
For stock control queries, please contact: 08457 419442, or email claims.customer_care@novartis.com
To access the full recall: